CISCRP Explores Impact of COVID-19 on Clinical Research
The recent public healthcare crisis has generated an increasing amount of attention on the topic of clinical research. CISCRP has conducted a survey among the public and patients in April 2020 to assess the impact of the pandemic on clinical research perceptions and experiences. Individuals in the United States and a few select countries in Europe completed the survey.
For the survey’s findings, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
